SuperworthAmneal Pharmaceuticals shares outstanding AMRX
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 328.1M
- On a year earlier
- +1.8%
- more shares
Amneal Pharmaceuticals had 328.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 328.1M | +6% |
| FY2024 | 309.9M | +27% |
| FY2023 | 243.7M | +61% |
| FY2022 | 151.5M | +1% |
| FY2021 | 149.4M | +1% |
| FY2020 | 147.6M | +4% |
| FY2019 | 141.9M | +11% |
| FY2018 | 127.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 328.1M | +2% | |
| Q1 FY26 | 328.9M | +2% | |
| Q4 FY25 | 328.1M | +6% | |
| Q3 FY25 | 324.8M | +5% | |
| Q2 FY25 | 322.4M | +1% | |
| Q1 FY25 | 324M | +5% | |
| Q4 FY24 | 309.9M | +27% | |
| Q3 FY24 | 309.6M | +94% | |
| Q2 FY24 | 319M | +106% | |
| Q1 FY24 | 307.3M | +102% | |
| Q4 FY23 | 243.7M | +61% | |
| Q3 FY23 | 159.7M | +5% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Amneal Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.